Finance

Beta
Lists
196170:KOSDAQ
Alteogen Inc
₩289,500.00
-12.93%
(-43,000.00) 1D
Jun 8, 3:30:17 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 196170...
Open
₩312,500
High
₩315,000
Low
₩286,000
Mkt. cap
15.51T
Avg. vol.
498.76K
Volume
571.83K
Dividend
0.13%
Quarterly dividend
₩93
Ex-dividend date
Dec 29, 2025
P/E ratio
126.32
52-wk high
₩569,000
52-wk low
₩286,000
EPS
₩2,292
Shares outstanding
53.59M
No. of employees
172
Open
₩312,500
High
₩315,000
Low
₩286,000
Mkt. cap
15.51T
Avg. vol.
498.76K
Volume
571.83K
Dividend
0.13%
Quarterly dividend
₩93
Ex-dividend date
Dec 29, 2025
P/E ratio
126.32
52-wk high
₩569,000
52-wk low
₩286,000
EPS
₩2,292
Shares outstanding
53.59M
No. of employees
172
News stories
From sources across the web
About Alteogen Inc
CEOSoon Jae Park
Employees172
Founded2008
Headquarters-
SectorBiotechnology
Websitealteogen.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
18.64B
49.01B
64.51B
71.60B
Cost of goods sold
6.58B
9.16B
21.94B
10.07B
Cost of revenue
6.58B
9.16B
21.94B
10.07B
Research and development expenses
8.21B
7.96B
14.91B
15.39B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.73B
4.24B
5.56B
6.49B
Operating expense
12.49B
13.18B
22.93B
22.22B
Total operating expenses
19.07B
22.34B
44.87B
32.30B
Operating income
-426.29M
26.67B
19.64B
39.30B
Other non operating income
10.59B
-8.96M
46.64B
32.47B
EBT including unusual items
1.11B
30.36B
69.27B
83.68B
EBT excluding unusual items
1.06B
30.44B
68.48B
83.74B
Income tax expense
35.43B
8.33B
-5.16B
12.34B
Effective tax rate
3,182.15%
27.45%
-7.45%
14.75%
Other operating expenses
336.33M
104.90M
177.84M
82.10M
Net income
-33.09B
22.34B
69.24B
71.70B
Net profit margin
-177.51%
45.59%
107.33%
100.14%
Earnings per share
-
253.00
1.30K
913.00
Interest and investment income
2.87B
3.02B
3.34B
3.46B
Interest expense
-3.09B
-3.07B
-3.49B
-3.11B
Net interest expenses
-228.56M
-50.71M
-150.77M
352.60M
Depreciation and amortization charges
163.53M
195.01M
174.74M
204.36M
EBITDA
243.02M
28.03B
22.44B
42.20B
Gain or loss from assets sale
-
248.55K
14.00K
14.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer